DEUTSCHE BANK AG\ - CARDIOME PHARMA CORP ownership

CARDIOME PHARMA CORP's ticker is CRME and the CUSIP is 14159U301. A total of 27 filers reported holding CARDIOME PHARMA CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of CARDIOME PHARMA CORP
ValueSharesWeighting
Q1 2018$71,000
+57.8%
30,800
+5.1%
0.00%
Q4 2017$45,000
+150.0%
29,300
+602.8%
0.00%
Q2 2017$18,000
+1700.0%
4,169
+733.8%
0.00%
Q4 2016$1,0000.0%5000.0%0.00%
Q3 2016$1,000
-50.0%
500
+25.0%
0.00%
Q2 2016$2,000
-98.5%
400
-97.3%
0.00%
Q2 2015$137,000
+813.3%
14,599
+769.5%
0.00%
Q1 2015$15,000
+150.0%
1,679
+106.0%
0.00%
Q2 2014$6,000
-45.5%
815
-42.6%
0.00%
Q1 2014$11,000
+450.0%
1,420
+255.0%
0.00%
Q4 2013$2,000
-96.9%
400
-97.8%
0.00%
Q3 2013$64,00018,2990.00%
Other shareholders
CARDIOME PHARMA CORP shareholders Q4 2013
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,195,692$4,953,0002.97%
Tamarack Advisers, LP 1,875,000$2,906,0001.59%
CLOUGH CAPITAL PARTNERS L P 2,667,585$4,135,0000.34%
Rock Springs Capital Management LP 1,200,000$1,860,0000.08%
WESTFIELD CAPITAL MANAGEMENT CO LP 4,678,364$7,251,0000.06%
KNOTT DAVID M 67,978$105,0000.04%
PUTNAM INVESTMENTS LLC 6,184,266$9,586,0000.01%
AlphaOne Investment Services, LLC 10,625$16,0000.01%
A.R.T. Advisors, LLC 34,872$54,0000.00%
Virtu Financial LLC 11,693$18,0000.00%
View complete list of CARDIOME PHARMA CORP shareholders